Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Parkinson disease

*

* Not a rare disease

Other Names for this Disease

  • Paralysis agitans
  • Parkinson's disease
  • Primary parkinsonism
  • Shaking palsy
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Management Guidelines

  • GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. Click on the link to view the article on this topic.
  • The National Guideline Clearinghouse (NGC) is a public resource for evidence-based clinical practice guidelines. The NGC was originally created by the Agency for Healthcare Research and Quality (AHRQ) in partnership with the American Medical Association and the American Association of Health Plans.

Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Parkinson disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA) for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products" for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat other conditions by searching the Orphan Drug Product Designation database.


Generic Name Apomorphine HCL
Trade Name
(Manufacturer Name)
Apokyn®
(Ipsen Limited)
Indication
The FDA has approved this product to be used in this manner.
For the acute, intermittent treatment of hypomobility, "off" episodes ("end-of-dose-wearing-off" and unpredictable :on/off" episodes) associated with advanced Parkinson's disease
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Selegiline HCl
Trade Name
(Manufacturer Name)
Eldepryl
(Somerset Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
As an adjuvant to levodopa and carbidopa treatment of idiopathic Parkinson's disease (paralysis agitans), postencephalitic Parkinsonism, and symptomatic Parkinsonism.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name droxidopa
Trade Name
(Manufacturer Name)
Northera
(Chelsea Therapeutics, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of orthostatic dizziness, lightheadedness, or the "feeling that you are about to black out" in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure (Parkinson's disease, multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy.
More Information about this product Drug Information Portal

Other Names for this Disease
  • Paralysis agitans
  • Parkinson's disease
  • Primary parkinsonism
  • Shaking palsy
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.